Co-Diagnostics Announces Second Quarter 2026 Earnings Release Date and Webcast

Rhea-AI Summary

Co-Diagnostics (Nasdaq: CODX) announced it will release its second quarter 2026 financial results on Thursday, August 13, 2026, after market close. Management will discuss the results on a conference call and webcast the same day at 4:30 p.m. ET.

The event will feature CEO Dwight Egan, CFO Brian Brown, and Head of Investor Relations Andrew Benson. Investors can access the live webcast via the Events & Webcasts page at ir.co-dx.com or join by phone using the provided toll-free and toll numbers. A replay will later be available on the company’s website.

Market reaction after 2Q26 earnings report: CODX +15.89%

+15.89% $1.75

15m delay

+15.89% Vs previous close

$1.75 Last Price

$1.40 $1.75 Day Range

$6.02M Market Cap

0.2x Rel. Volume

Following this news, CODX has gained 15.89%, reflecting a significant positive market reaction. Our momentum scanner has triggered 18 alerts so far, indicating notable trading interest and price volatility. The stock is currently trading at $1.75.

Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.

Market Context

The stock is surging +15.9% following this news. Historical earnings-date reactions were +1.31% and ...

Analysis

The stock is surging +15.9% following this news. Historical earnings-date reactions were +1.31% and -8.4%, showing materially different outcomes for this event type. The active S-3 is a resale registration, so registered resales do not provide company proceeds.

Key Figures

Reporting period: Q2 2026 Release date: August 13, 2026 Webcast time: 4:30 p.m. ET

3 metrics

Reporting period Q2 2026 Financial results scheduled for release after market close

Release date August 13, 2026 Second-quarter 2026 financial results

Webcast time 4:30 p.m. ET Conference call and webcast on August 13, 2026

Previous Earnings date Reports

2 past events · Latest: Apr 30 (Neutral)

Same Type Pattern 2 events

Date	Event	Sentiment	24h Move	Catalyst
Apr 30	Earnings date	Neutral	+1.3%	First-quarter 2026 results release date and webcast announced
Mar 17	Earnings date	Neutral	-8.4%	Fourth-quarter and full-year 2025 results release date announced

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

The two prior earnings-date announcements produced mixed reactions of 1.31% and -8.4%, with an average move of -3.54%.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SALT LAKE CITY, July 30, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced it will release its second quarter 2026 financial results on Thursday, August 13, 2026, after the market close. The Company will also host a conference call and webcast on the same day at 4:30 p.m. ET to discuss its financial results with analysts. Management on the call will include Dwight Egan, Chief Executive Officer, Brian Brown, Chief Financial Officer, and Andrew Benson, Head of Investor Relations.

The conference call and webcast will be available via:

Webcast: ir.co-dx.com on the Events & Webcasts page, or accessible directly here

Conference Call: 1-888-880-3330 (Toll Free) or 1-646-357-8766 (Toll)

If you are unable to participate during the live webcast, the call will be recorded and later made available on the Company's website.

About Co-Diagnostics, Inc.:

Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technologies. The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform (subject to regulatory review and not currently for sale) and to identify genetic markers for use in applications other than infectious disease.

View original content to download multimedia:https://www.prnewswire.com/news-releases/co-diagnostics-announces-second-quarter-2026-earnings-release-date-and-webcast-302838779.html

SOURCE Co-Diagnostics

FAQ

When will Co-Diagnostics (NASDAQ: CODX) release its Q2 2026 earnings?

Co-Diagnostics will release its second quarter 2026 financial results on Thursday, August 13, 2026, after the market close. According to Co-Diagnostics, the earnings release will be followed by a conference call and webcast at 4:30 p.m. ET the same day.

What time is the Co-Diagnostics (CODX) Q2 2026 earnings conference call and webcast?

The Co-Diagnostics Q2 2026 earnings conference call and webcast is scheduled for 4:30 p.m. ET on August 13, 2026. According to Co-Diagnostics, management will discuss the quarterly financial results with analysts immediately following the after-market-close earnings release.

How can investors access the Co-Diagnostics (CODX) Q2 2026 earnings webcast?

Investors can access the Co-Diagnostics Q2 2026 earnings webcast via ir.co-dx.com on the Events & Webcasts page. According to Co-Diagnostics, the webcast will cover management’s discussion of second quarter 2026 financial results on August 13, 2026, at 4:30 p.m. ET.

What are the dial-in numbers for the Co-Diagnostics (CODX) Q2 2026 earnings conference call?

The dial-in numbers are 1-888-880-3330 (toll free) and 1-646-357-8766 (toll). According to Co-Diagnostics, callers can use these numbers to join the second quarter 2026 earnings call on August 13, 2026, at 4:30 p.m. ET.

Will a replay be available for the Co-Diagnostics (CODX) Q2 2026 earnings call?

Yes, a replay of the Co-Diagnostics Q2 2026 earnings call will be available on the company’s website. According to Co-Diagnostics, the live event will be recorded and later posted online for investors who cannot participate in the live webcast.

Who from Co-Diagnostics management will speak on the Q2 2026 earnings call?

Speakers will include CEO Dwight Egan, CFO Brian Brown, and Head of Investor Relations Andrew Benson. According to Co-Diagnostics, this team will review and discuss the company’s second quarter 2026 financial results with analysts on August 13, 2026.